Top 35 Therapeutic Targets Analysis in Therapeutic Partnering 2010 – 2015 Report

1
Trends in Therapeutic Partnering 2010-2015
Order this report by calling 1 888 391 5441 or
Send an email to sales_at_reportsandreports.com with
your contact details and questions if any.

• Published July 2015
• No. of Pages 4330
• Single User PDF US 3995

2
Trends in Therapeutic Partnering 2010-2015
The Trends in Therapeutic Partnering 2010-2015
report provides the most comprehensive and
in-depth insight into the 35 most popular
therapeutic targets for partnering in the period
2010 to mid 2015. The report provides a detailed
understanding and analysis of the most popular
therapeutic targets for partnering in the period
2010 to mid 2015. The majority of deals are
discovery, preclinical and clinical stage whereby
the licensee obtains a right or an option right
to license or access the licensors compounds or
product candidates. These deals tend to be
multicomponent, starting with collaborative RD,
and commercialization of outcomes. One of the
key aspects of partnering is finding those
companies that are potential candidates for the
development and commercialization of the next
generation of therapeutic targets. A lot of
resources are spent on finding partners,
identifying their interests and making contact to
initiate discussions. Using this report,
dealmakers will effectively and efficiently
target their partnering activities to deliver the
company's business development objectives. Over
300 charts allow quick understanding of
therapeutic partnering trends since 2010,
together with insight into which companies are
active in each of the thirty five leading
therapeutic areas. Complete Report available at
http//www.reportsnreports.com/reports/267194-tren
ds-in-therapeutic-partnering-2010-2015.html.
Order this report by calling 1 888 391 5441 or
Send an email to sales_at_reportsandreports.com with
your contact details and questions if any.
3
Trends in Therapeutic Partnering 2010-2015

• Understanding the flexibility of a prospective
  partner's negotiated deals terms provides
  critical insight into the negotiation process in
  terms of what you can expect to achieve during
  the negotiation of terms. Whilst many smaller
  companies will be seeking details of the payments
  clauses, the devil is in the detail in terms of
  how payments are triggered - contract documents
  provide this insight where press releases and
  databases do not.
• The initial chapters of this report provide an
  orientation of therapeutic dealmaking.
• Chapter 1 provides an introduction to the report,
  whilst chapter 2 provides an overview of
  therapeutic dealmaking since 2010, listing the
  top therapeutic areas for partnering by deal
  frequency and deal dollars committed by
  partnering companies.
• Chapter 3 reviews the top pharma and biotech
  therapeutic partnering deals of 2010-2015
  according to reported deal size.
• Chapter 4 provides a summary on best practice on
  how to submit an opportunity to the leading
  therapeutic partnering companies, to ensure
  building of relationships and to obtain a prompt
  assessment and response from the business
  development function of the prospective
• partner.
• Purchase a Copy of this report _at_
  http//www.reportsnreports.com/purchase.aspx?name
  267194.

Order this report by calling 1 888 391 5441 or
Send an email to sales_at_reportsandreports.com with
your contact details and questions if any.
4
Trends in Therapeutic Partnering 2010-2015

• Chapter 5 lists forthcoming partnering events
  where valuable face to face meetings with
  biopharma companies provide a highly effective
  means of obtaining interest in novel
  opportunities. These events are where dealmaking
  gets initiated through numerous back to back
  meetings.
• The main body of the report is provided in
  chapter 6. In-depth profiles of each of the top
  35 therapeutic target areas according to deal
  frequency during the period 2010-2015 provide
  everything required to assess the potential of
  the therapeutic area and its active partner
  companies. Each profile includes a partnering
  activity overview, deal financials (including
  headline, upfront and royalties rates, where
  available).
• Each therapeutic profile provides a listing of
  partnering deals for the top fifiteen most active
  companies in each therapeutic area, and is
  accompanied by an appendix that provides a
  comprehensive listing of deal records available
  at Current Agreements, each of which links direct
  to an online copy of the actual deal record plus
  contract document if filed with the SEC.
• One of the key aspects of partnering is
  conducting due diligence on a partner to
  determine under what terms a prospective partner
  agrees to a partnering relationship.

Inquiry for Discount _at_ http//www.reportsnreports
.com/contacts/discount.aspx?name267194.
Order this report by calling 1 888 391 5441 or
Send an email to sales_at_reportsandreports.com with
your contact details and questions if any.
5
Trends in Therapeutic Partnering 2010-2015

• Understanding the flexibility of a prospective
  partners' negiotated deals terms provides
  critical insight into the negotiation process in
  terms of what you can expect to achieve during
  the negotiation of terms. Whilst many smaller
  companies will be seeking details of the payments
  clauses, the devil is in the detail in terms of
  how payments are triggered - contract documents
  provide this insight where press releases and
  databases do not.
• This data driven report contains over 5,000 links
  to online copies of actual deal records at
  Current Agreements and contract documents, where
  submitted to the Securities Exchange Commission
  by companies and their partners. Contract
  documents provide the answers to numerous
  questions about a prospective partner's
  flexibility on a wide range of important issues,
  many of which will have a significant impact on
  each party's ability to derive value from the
  deal.
• In addition, contract documents provide the
  answers to numerous questions about a prospective
  partner's flexibility on a wide range of
  important issues, many of which will have a
  significant impact on each party's ability to
  derive value from the deal.
• In summary, the report provides the reader with
  the tools necessary to understand trends in
  therapeutic partnering, the most active
  therapeutic areas in terms of deal frequency and
  leading deal maker companies, and the deal terms
  and structures achieved in such therapeutic
  partnering deals.

Download PDF at http//www.reportsnreports.com/con
tacts/requestsample.aspx?name267194.
Order this report by calling 1 888 391 5441 or
Send an email to sales_at_reportsandreports.com with
your contact details and questions if any.
6
Trends in Therapeutic Partnering 2010-2015

• Report scope
• Trends in Therapeutic Partnering 2010-2015 is
  intended to provide the reader with an in-depth
  understanding of therapeutic partnering trends
  and structure of deals entered into by leading
  companies worldwide.
• Trends in Therapeutic Partnering 2010-2015
  includes
• Trends in therapeutic dealmaking in the
  biopharma industry since 2010
• Analysis of therapeutic partnering deal
  structure
• Access to over 5,000 therapeutic partnering
  deals
• The top 35 therapeutic targets for partnering
  since 2009
• The leading therapeutic partnering deals by
  value since 2010
• Most active therapeutic partnering dealmakers
  since 2010

Request Sample for this Report _at_
http//www.reportsnreports.com/contacts/requestsam
ple.aspx?name267194.
Order this report by calling 1 888 391 5441 or
Send an email to sales_at_reportsandreports.com with
your contact details and questions if any.
7
Trends in Therapeutic Partnering 2010-2015

• In Trends in Therapeutic Partnering 2010-2015,
  the available deals are listed by
• Most active companies in partnering for each
  therapeutic area
• Headline value
• Upfront payment
• Royalty rate
• Company A-Z
• Each deal title links to online deal records of
  actual therapeutic partnering deals as disclosed
  by the deal parties. In addition, where
  available, records include contract documents as
  submitted to the Securities Exchange Commission
  by companies and their partners.
• The Trends in Therapeutic Partnering 2010-2015
  report provides comprehensive access to available
  deal records for over 5,000 therapeutic target
  partnering deals.

Complete Report available at http//www.reportsnre
ports.com/reports/267194-trends-in-therapeutic-par
tnering-2010-2015.html.
Order this report by calling 1 888 391 5441 or
Send an email to sales_at_reportsandreports.com with
your contact details and questions if any.
8
Trends in Therapeutic Partnering 2010-2015

• Analyzing actual contract agreements allows
  assessment of the following
• What are the precise rights granted or
  optioned?
• What is actually granted by the agreement to
  the partner company?
• What exclusivity is granted?
• What is the payment structure for the deal?
• How aresalesand payments audited?
• What is the deal term?
• How are the key terms of the agreement
  defined?
• How are IPRs handled and owned?
• Who is responsible for commercialization?
• Who is responsible for development, supply,
  and manufacture?
• How is confidentiality and publication
  managed?
• How are disputes to be resolved?
• Under what conditions can the deal be
  terminated?
• What happens when there is a change of
  ownership?

Inquire for Discount at http//www.reportsnreports
.com/contacts/discount.aspx?name267194.
Order this report by calling 1 888 391 5441 or
Send an email to sales_at_reportsandreports.com with
your contact details and questions if any.
9
Trends in Therapeutic Partnering 2010-2015

• Benefits
• Trends in Therapeutic Partnering 2010- 2015
  provides the reader with the following key
  benefits
• In-depth understanding of therapeutic
  partnering trends since 2010
• Analysis of the top 35 therapeutic target
  areas for partnering and the deal structure
• Identify the most active therapeutic
  partnering dealmakers since 2010
• Comprehensive access to over 5,000 actual
  partnering deals as recorded at Current
  Agreement, together with contract documents if
  available
• Detailed access to actual therapeutic
  partnering deals entered into by the leading
  fifty big pharma and big biotech companies
• Insight into the terms included in a
  therapeutic partnering agreement, together with
  real world clause examples
• Understand the key deal terms companies have
  agreed in previous deals
• Undertake due diligence to assess suitability
  of your proposed deal terms for partner companies
• Full listing of partnering deals by headline
  value, upfront payment, royalty rate and company
  A-Z

Purchase a Copy of this report _at_
http//www.reportsnreports.com/purchase.aspx?name
267194.
Order this report by calling 1 888 391 5441 or
Send an email to sales_at_reportsandreports.com with
your contact details and questions if any.